169 related articles for article (PubMed ID: 30528960)
1. Neurocognitive and neuroanatomical maturation in the clinical high-risk states for psychosis: A pattern recognition study.
Kambeitz-Ilankovic L; Haas SS; Meisenzahl E; Dwyer DB; Weiske J; Peters H; Möller HJ; Falkai P; Koutsouleris N
Neuroimage Clin; 2019; 21():101624. PubMed ID: 30528960
[TBL] [Abstract][Full Text] [Related]
2. Use of Machine Learning to Determine Deviance in Neuroanatomical Maturity Associated With Future Psychosis in Youths at Clinically High Risk.
Chung Y; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; McEwen S; van Erp TGM; Cannon TD;
JAMA Psychiatry; 2018 Sep; 75(9):960-968. PubMed ID: 29971330
[TBL] [Abstract][Full Text] [Related]
3. Prediction Models of Functional Outcomes for Individuals in the Clinical High-Risk State for Psychosis or With Recent-Onset Depression: A Multimodal, Multisite Machine Learning Analysis.
Koutsouleris N; Kambeitz-Ilankovic L; Ruhrmann S; Rosen M; Ruef A; Dwyer DB; Paolini M; Chisholm K; Kambeitz J; Haidl T; Schmidt A; Gillam J; Schultze-Lutter F; Falkai P; Reiser M; Riecher-Rössler A; Upthegrove R; Hietala J; Salokangas RKR; Pantelis C; Meisenzahl E; Wood SJ; Beque D; Brambilla P; Borgwardt S;
JAMA Psychiatry; 2018 Nov; 75(11):1156-1172. PubMed ID: 30267047
[TBL] [Abstract][Full Text] [Related]
4. Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for Psychosis.
Modinos G; Kempton MJ; Tognin S; Calem M; Porffy L; Antoniades M; Mason A; Azis M; Allen P; Nelson B; McGorry P; Pantelis C; Riecher-Rössler A; Borgwardt S; Bressan R; Barrantes-Vidal N; Krebs MO; Nordentoft M; Glenthøj B; Ruhrmann S; Sachs G; Rutten B; van Os J; de Haan L; Velthorst E; van der Gaag M; Valmaggia LR; McGuire P;
JAMA Psychiatry; 2020 Feb; 77(2):190-200. PubMed ID: 31722018
[TBL] [Abstract][Full Text] [Related]
5. Cortical abnormalities in youth at clinical high-risk for psychosis: Findings from the NAPLS2 cohort.
Chung Y; Allswede D; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; McEwen S; van Erp TGM; Cannon TD;
Neuroimage Clin; 2019; 23():101862. PubMed ID: 31150956
[TBL] [Abstract][Full Text] [Related]
6. Neurocognitive Assessments Are More Important Among Adolescents Than Adults for Predicting Psychosis in Clinical High Risk.
Zhang T; Cui H; Wei Y; Tang X; Xu L; Hu Y; Tang Y; Chen T; Li C; Wang J
Biol Psychiatry Cogn Neurosci Neuroimaging; 2022 Jan; 7(1):56-65. PubMed ID: 34274517
[TBL] [Abstract][Full Text] [Related]
7. Baseline Cortical Thickness Reductions in Clinical High Risk for Psychosis: Brain Regions Associated with Conversion to Psychosis Versus Non-Conversion as Assessed at One-Year Follow-Up in the Shanghai-At-Risk-for-Psychosis (SHARP) Study.
Del Re EC; Stone WS; Bouix S; Seitz J; Zeng V; Guliano A; Somes N; Zhang T; Reid B; Lyall A; Lyons M; Li H; Whitfield-Gabrieli S; Keshavan M; Seidman LJ; McCarley RW; Wang J; Tang Y; Shenton ME; Niznikiewicz MA
Schizophr Bull; 2021 Mar; 47(2):562-574. PubMed ID: 32926141
[TBL] [Abstract][Full Text] [Related]
8. Normative Modeling of Brain Morphometry in Clinical High Risk for Psychosis.
; Haas SS; Ge R; Agartz I; Amminger GP; Andreassen OA; Bachman P; Baeza I; Choi S; Colibazzi T; Cropley VL; de la Fuente-Sandoval C; Ebdrup BH; Fortea A; Fusar-Poli P; Glenthøj BY; Glenthøj LB; Haut KM; Hayes RA; Heekeren K; Hooker CI; Hwang WJ; Jahanshad N; Kaess M; Kasai K; Katagiri N; Kim M; Kindler J; Koike S; Kristensen TD; Kwon JS; Lawrie SM; Lebedeva I; Lee J; Lemmers-Jansen ILJ; Lin A; Ma X; Mathalon DH; McGuire P; Michel C; Mizrahi R; Mizuno M; Møller P; Mora-Durán R; Nelson B; Nemoto T; Nordentoft M; Nordholm D; Omelchenko MA; Pantelis C; Pariente JC; Raghava JM; Reyes-Madrigal F; Røssberg JI; Rössler W; Salisbury DF; Sasabayashi D; Schall U; Smigielski L; Sugranyes G; Suzuki M; Takahashi T; Tamnes CK; Theodoridou A; Thomopoulos SI; Thompson PM; Tomyshev AS; Uhlhaas PJ; Værnes TG; van Amelsvoort TAMJ; van Erp TGM; Waltz JA; Wenneberg C; Westlye LT; Wood SJ; Zhou JH; Hernaus D; Jalbrzikowski M; Kahn RS; Corcoran CM; Frangou S
JAMA Psychiatry; 2024 Jan; 81(1):77-88. PubMed ID: 37819650
[TBL] [Abstract][Full Text] [Related]
9. Using brain structural neuroimaging measures to predict psychosis onset for individuals at clinical high-risk.
Zhu Y; Maikusa N; Radua J; Sämann PG; Fusar-Poli P; Agartz I; Andreassen OA; Bachman P; Baeza I; Chen X; Choi S; Corcoran CM; Ebdrup BH; Fortea A; Garani RR; Glenthøj BY; Glenthøj LB; Haas SS; Hamilton HK; Hayes RA; He Y; Heekeren K; Kasai K; Katagiri N; Kim M; Kristensen TD; Kwon JS; Lawrie SM; Lebedeva I; Lee J; Loewy RL; Mathalon DH; McGuire P; Mizrahi R; Mizuno M; Møller P; Nemoto T; Nordholm D; Omelchenko MA; Raghava JM; Røssberg JI; Rössler W; Salisbury DF; Sasabayashi D; Smigielski L; Sugranyes G; Takahashi T; Tamnes CK; Tang J; Theodoridou A; Tomyshev AS; Uhlhaas PJ; Værnes TG; van Amelsvoort TAMJ; Waltz JA; Westlye LT; Zhou JH; Thompson PM; Hernaus D; Jalbrzikowski M; Koike S;
Mol Psychiatry; 2024 May; 29(5):1465-1477. PubMed ID: 38332374
[TBL] [Abstract][Full Text] [Related]
10. Brain network characteristics separating individuals at clinical high risk for psychosis into normality or psychosis.
Choi SH; Kyeong S; Cho KIK; Yun JY; Lee TY; Park HY; Kim SN; Kwon JS
Schizophr Res; 2017 Dec; 190():107-114. PubMed ID: 28325573
[TBL] [Abstract][Full Text] [Related]
11. Altered relationships between age and functional brain activation in adolescents at clinical high risk for psychosis.
Karlsgodt KH; van Erp TG; Bearden CE; Cannon TD
Psychiatry Res; 2014 Jan; 221(1):21-9. PubMed ID: 24144510
[TBL] [Abstract][Full Text] [Related]
12. Associations between age and neurocognition in individuals at clinical high risk and first-episode psychosis.
Zhang T; Wei Y; Cui H; Tang X; Xu L; Hu Y; Tang Y; Liu H; Chen T; Li C; Wang J
Psychiatry Res; 2023 Sep; 327():115385. PubMed ID: 37567111
[TBL] [Abstract][Full Text] [Related]
13. Cognitive dysfunction in a psychotropic medication-naïve, clinical high-risk sample from the ShangHai-At-Risk-for-Psychosis (SHARP) study: Associations with clinical outcomes.
Cui H; Giuliano AJ; Zhang T; Xu L; Wei Y; Tang Y; Qian Z; Stone LM; Li H; Whitfield-Gabrieli S; Niznikiewicz M; Keshavan MS; Shenton ME; Wang J; Stone WS
Schizophr Res; 2020 Dec; 226():138-146. PubMed ID: 32694037
[TBL] [Abstract][Full Text] [Related]
14. Neuroanatomical heterogeneity and homogeneity in individuals at clinical high risk for psychosis.
Baldwin H; Radua J; Antoniades M; Haas SS; Frangou S; Agartz I; Allen P; Andreassen OA; Atkinson K; Bachman P; Baeza I; Bartholomeusz CF; Chee MWL; Colibazzi T; Cooper RE; Corcoran CM; Cropley VL; Ebdrup BH; Fortea A; Glenthøj LB; Hamilton HK; Haut KM; Hayes RA; He Y; Heekeren K; Kaess M; Kasai K; Katagiri N; Kim M; Kindler J; Klaunig MJ; Koike S; Koppel A; Kristensen TD; Bin Kwak Y; Kwon JS; Lawrie SM; Lebedeva I; Lee J; Lin A; Loewy RL; Mathalon DH; Michel C; Mizrahi R; Møller P; Nelson B; Nemoto T; Nordholm D; Omelchenko MA; Pantelis C; Raghava JM; Røssberg JI; Rössler W; Salisbury DF; Sasabayashi D; Schall U; Smigielski L; Sugranyes G; Suzuki M; Takahashi T; Tamnes CK; Tang J; Theodoridou A; Thomopoulos SI; Tomyshev AS; Uhlhaas PJ; Værnes TG; van Amelsvoort TAMJ; Van Erp TGM; Waltz JA; Westlye LT; Wood SJ; Zhou JH; McGuire P; Thompson PM; Jalbrzikowski M; Hernaus D; Fusar-Poli P;
Transl Psychiatry; 2022 Jul; 12(1):297. PubMed ID: 35882855
[TBL] [Abstract][Full Text] [Related]
15. Abnormal relationships between local and global brain measures in subjects at clinical high risk for psychosis: a pilot study.
Konishi J; Del Re EC; Bouix S; Blokland GAM; Mesholam-Gately R; Woodberry K; Niznikiewicz M; Goldstein J; Hirayasu Y; Petryshen TL; Seidman LJ; Shenton ME; McCarley RW
Brain Imaging Behav; 2018 Aug; 12(4):974-988. PubMed ID: 28815390
[TBL] [Abstract][Full Text] [Related]
16. A systematic review and meta-analysis of structural and functional brain alterations in individuals with genetic and clinical high-risk for psychosis and bipolar disorder.
Luna LP; Radua J; Fortea L; Sugranyes G; Fortea A; Fusar-Poli P; Smith L; Firth J; Shin JI; Brunoni AR; Husain MI; Husian MO; Sair HI; Mendes WO; Uchoa LRA; Berk M; Maes M; Daskalakis ZJ; Frangou S; Fornaro M; Vieta E; Stubbs B; Solmi M; Carvalho AF
Prog Neuropsychopharmacol Biol Psychiatry; 2022 Jul; 117():110540. PubMed ID: 35240226
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychological Test Performance to Enhance Identification of Subjects at Clinical High Risk for Psychosis and to Be Most Promising for Predictive Algorithms for Conversion to Psychosis: A Meta-Analysis.
Hauser M; Zhang JP; Sheridan EM; Burdick KE; Mogil R; Kane JM; Auther A; Carrión RE; Cornblatt BA; Correll CU
J Clin Psychiatry; 2017 Jan; 78(1):e28-e40. PubMed ID: 28129494
[TBL] [Abstract][Full Text] [Related]
18. Global and Specific Cortical Volume Asymmetries in Individuals With Psychosis Risk Syndrome and Schizophrenia: A Mixed Cross-sectional and Longitudinal Perspective.
Damme KSF; Vargas T; Calhoun V; Turner J; Mittal VA
Schizophr Bull; 2020 Apr; 46(3):713-721. PubMed ID: 31682728
[TBL] [Abstract][Full Text] [Related]
19. From the psychosis prodrome to the first-episode of psychosis: No evidence of a cognitive decline.
Carrión RE; Walder DJ; Auther AM; McLaughlin D; Zyla HO; Adelsheim S; Calkins R; Carter CS; McFarland B; Melton R; Niendam T; Ragland JD; Sale TG; Taylor SF; McFarlane WR; Cornblatt BA
J Psychiatr Res; 2018 Jan; 96():231-238. PubMed ID: 29121595
[TBL] [Abstract][Full Text] [Related]
20. Multimodal Machine Learning Workflows for Prediction of Psychosis in Patients With Clinical High-Risk Syndromes and Recent-Onset Depression.
Koutsouleris N; Dwyer DB; Degenhardt F; Maj C; Urquijo-Castro MF; Sanfelici R; Popovic D; Oeztuerk O; Haas SS; Weiske J; Ruef A; Kambeitz-Ilankovic L; Antonucci LA; Neufang S; Schmidt-Kraepelin C; Ruhrmann S; Penzel N; Kambeitz J; Haidl TK; Rosen M; Chisholm K; Riecher-Rössler A; Egloff L; Schmidt A; Andreou C; Hietala J; Schirmer T; Romer G; Walger P; Franscini M; Traber-Walker N; Schimmelmann BG; Flückiger R; Michel C; Rössler W; Borisov O; Krawitz PM; Heekeren K; Buechler R; Pantelis C; Falkai P; Salokangas RKR; Lencer R; Bertolino A; Borgwardt S; Noethen M; Brambilla P; Wood SJ; Upthegrove R; Schultze-Lutter F; Theodoridou A; Meisenzahl E;
JAMA Psychiatry; 2021 Feb; 78(2):195-209. PubMed ID: 33263726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
